<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="HD72FC6E96CD04359A566FF19B27853DF" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>117 HR 6513 IH: Medical Innovation Acceleration Act of 2022</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2022-01-28</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">117th CONGRESS</congress><session display="yes">2d Session</session><legis-num display="yes">H. R. 6513</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20220128">January 28, 2022</action-date><action-desc><sponsor name-id="B001302">Mr. Biggs</sponsor> introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Federal Food, Drug, and Cosmetic Act to exempt from regulation as devices non-invasive diagnostic devices, and for other purposes.</official-title></form><legis-body id="H2734FF621A6442CC964428FE8E0A7382" style="OLC"><section id="HD438BD03CFC147DDA0BDB385DEC27E7C" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Medical Innovation Acceleration Act of 2022</short-title></quote>. </text></section><section id="H6F42DF159DFF4AAE8A17B9C971326A2F"><enum>2.</enum><header>Exempting non-invasive diagnostic devices from regulation as devices</header><text display-inline="no-display-inline">Section 201(h) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/321">21 U.S.C. 321(h)</external-xref>) is amendedâ€”</text><paragraph id="HBA7D5CDC2F47467BB0D94D953DA3BBE0"><enum>(1)</enum><text>in the second sentence by inserting before the period at the end the following: <quote>or any non-invasive diagnostic device</quote>; and</text></paragraph><paragraph id="HCEEB02B7F1E848F18658CD329B2A0F14"><enum>(2)</enum><text>by adding at the end the following: <quote>For purposes of the preceding sentence, the term <quote>non-invasive</quote> means, with respect to a diagnostic device, that the device does not penetrate the skin or any other membrane of the body, is not inserted or implanted into the body, causes no more than ephemeral compression or temperature changes to in situ bodily tissues, and does not subject bodily tissues to ionizing radiation.</quote>. </text></paragraph></section></legis-body></bill> 

